BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
7.40
-0.29 (-3.77%)
Jun 26, 2026, 4:00 PM EDT - Market closed
BBOT Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, BBOT stock has a consensus rating of "Strong Buy" and an average price target of $25.11. The average 1-year stock price forecast is 239.32% higher than the current stock price, while the lowest is $18 (+143.24%) and the highest is $41 (+454.05%).
Price Target: $25.11 (+239.32%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BBOT stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 7 | 7 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Mazahir Alimohamed Oppenheimer No rating | Oppenheimer | Buy Maintains $22 | Buy | Maintains | $22 | +197.30% | Jun 22, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $23 | Buy | Maintains | $23 | +210.81% | Jun 8, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $21 | Buy | Maintains | $21 | +183.78% | Jun 1, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $18 | Buy | Maintains | $18 | +143.24% | May 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $25 | Buy | Maintains | $25 | +237.84% | May 14, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.23
from -4.30
EPS Next Year
-2.13
from -2.23
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | ||
| Avg | n/a | ||
| Low | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.72 | ||
| Avg | -2.23 | ||
| Low | -2.72 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |